Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - WORLD HEALTH ENERGY HOLDINGS, INC.ex31-2.htm
EXCEL - IDEA: XBRL DOCUMENT - WORLD HEALTH ENERGY HOLDINGS, INC.Financial_Report.xls
EX-32.2 - EXHIBIT 32.2 - WORLD HEALTH ENERGY HOLDINGS, INC.ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - WORLD HEALTH ENERGY HOLDINGS, INC.ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - WORLD HEALTH ENERGY HOLDINGS, INC.ex31-1.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

(Mark One)

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2013

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to ___________

 

Commission file number 000-29462

 

WORLD HEALTH ENERGY HOLDINGS, INC.

(Name of small business issuer in its charter)

 

Delaware   59-2762023

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

511 Avenue of the Americas #710

New York, NY

(Address of principal executive offices)

 

10011

(Zip Code)

 

Issuers telephone number: (212) 884-8395

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

None

 

Securities registered pursuant to Section 12(g) of the Exchange Act:

 

Common Stock, Par Value $0.0007 Per Share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [  ] No [X]

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [  ] No [X]

 

Indicate by check mark whether the issuer (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [X]

 

Indicate by check mark whether the registrant is a large accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ] Accelerated filer [  ]
Non-accelerated filer [  ] Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [  ] No [X]

 

As of September 30, 2013, the Registrant had 19,789,407,996 outstanding shares of its common stock, $0.0007 par value.

 

Transitional Small Business Disclosure Format (check one): Yes [  ] No [X]

 

DOCUMENTS INCORPORATED BY REFERENCE

 

None

 

 

  

 
 

 

INDEX

 

PART I. - FINANCIAL INFORMATION   
    
Item 1. Financial Statements  F-1
    
Item 2 Management’s Discussion and Analysis or Plan of Operations  3
    
Item 3 Quantitative and Qualitative Disclosures About Market Risk  4
    
Item 4T. Controls and Procedures  5
    
PART II. - OTHER INFORMATION   
    
Item 1 Legal Proceedings  5
    
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds  5
    
Item 3 Defaults Upon Senior Securities  5
    
Item 4 Submission of Matters to a Vote of Security Holders  5
    
Item 5 Other Information  5
    
Item 6 Exhibits  6
    
SIGNATURES  7

 

2
 

 

PART I. - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

Consolidated Balance Sheets  F-2
    
Consolidated Statements of Operations  F-3
    
Consolidated Statement of Stockholders’ Deficit  F-4
    
Consolidated Statements of Cash Flows  F-5
    
Notes to Consolidated Financial Statements  F-6

 

F-1
 

 

WORLD HEALTH ENERGY HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS

 

   September 30, 2013   December 31, 2012 
         
ASSETS          
           
CURRENT ASSETS          
Cash  $-   $- 
           
PROPERTY AND EQUIPMENT          
Furniture, fixtures and equipment   4,353    4,353 
Less: Accumulated depreciation   4,353    4,353 
    -    - 
           
TOTAL ASSETS  $-   $- 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
           
CURRENT LIABILITIES          
Accounts payable and accrued liabilities  $79,284   $76,453 
Due to affiliates   330,172    284,842 
    409,456    361,295 
           
STOCKHOLDERS’ DEFICIT          
Preferred stock, $0.0007 par value, authorized 10,000,000 shares; 2,500,000 issued and outstanding   1,750    1,750 
           
Common stock, $0.0007 par value, authorized 110,000,000,000 shares; 19,789,407,996 issued and outstanding   13,852,585    13,852,585 
           
Additional paid in capital   11,433,491    11,433,491 
Accumulated deficit   (25,697,282)   (25,649,121)
    (409,456)   (361,295)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $-   $- 

 

See Accompanying Notes to Consolidated Financial Statements.

 

F-2
 

  

WORLD HEALTH ENERGY HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   For the 3 Months Ended   For the 9 Months Ended 
   Sep 30, 2013   Sep 30, 2012   Sep 30, 2013   Sep 30, 2012 
                 
REVENUE  $-   $-   $-   $- 
COST OF SALES   -    -    -    - 
GROSS MARGIN   -    -    -    - 
                     
OPERATING EXPENSES                    
General and administrative   1,517    19,216    24,473    68,903 
Professional fees   -    8,470    23,688    41,544 
Total expenses   1,517    27,686    48,161    110,447 
                     
LOSS FROM OPERATIONS   1,517    27,686    48,161    110,447 
                     
Loss on impairment   -    -    -    - 
                     
NET LOSS  $1,517   $27,686   $48,161   $110,447 
                     
LOSS PER WEIGHTED AVERAGE COMMON SHARES  $0.00   $0.00   $0.00   $0.00 
                     
NUMBER OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING   19,789,407,996    13,303,762,598    19,789,407,996    13,303,762,598 

 

See Accompanying Notes to Consolidated Financial Statements.

 

F-3
 

  

WORLD HEALTH ENERGY HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDER’S DEFICIT

 

   Number of
Shares-
Preferred
   Preferred
Stock
   Number of
Shares-
Common
   Common
Stock
   Additional
Paid-in Capital
   Accumulated Deficit   Total
Stockholders’ Deficit
 
Balance, December 31, 2011   2,500,000   $1,750    4,236,402,012   $2,965,481   $22,298,995   $(25,514,216)  $(247,990)
                                    
Shares issued for acquisition   -    -    15,553,005,984    10,887,104    (10,865,504)   -    21,600 
Net loss   -    -    -    -    -    (134,905)   (134,905)
                                    
Balance, December 31, 2012   2,500,000    1,750    19,789,407,996    13,852,585    11,433,491    (25,649,121)   (361,295)
                                    
Net loss   -    -    -    -    -    (48,161)   (48,161)
                                    
Balance, September 30, 2013   2,500,000   $1,750    19,789,407,996   $13,852,585   $11,433,491   $(25,697,282)  $(409,456)

 

See Accompanying Notes to Consolidated Financial Statements.

 

F-4
 

 

WORLD HEALTH ENERGY HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   For the Nine Months Ended 
   Sep 30, 2013   Sep 30, 2012 
Cash flows from operating activities:          
           
Net loss  $(48,161)  $(110,447)
           
Changes in:          
Accounts payable and accrued liabilities   2,831    26,512 
           
Net cash from operating activities   (45,330)   (83,935)
           
Cash flows from financing activities:          
           
Advances from affiliates   45,330    83,638 
           
Change in cash   -    (297)
           
Cash, beginning of period   -    212 
           
Cash, end of period  $-   $- 

 

See Accompanying Notes to Consolidated Financial Statements.

 

F-5
 

  

WORLD HEALTH ENERGY HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(1) Nature of Business

 

The consolidated financial statements include the accounts of World Health Energy Holdings, Inc. (“WHEH”) and its wholly owned subsidiary, World Health Energy, Inc. (“WHE”).

 

The Company’s corporate offices are located in New York City, New York.

 

(2) Basis of Presentation

 

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) on the accrual basis of accounting. All significant intercompany accounts and transactions have been eliminated in consolidation. The interim financial statements reflect all adjustments, which are, in the opinion of management, necessary in order to make the financial statements not misleading.

 

(3) Significant Accounting Policies

 

a) Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

 

b) Loss per share

 

The Company has adopted Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 260-10-50, Earnings Per Share, which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Basic and diluted losses per share were the same at the reporting dates as there were no common stock equivalents outstanding at September 30, 2013 or December 31, 2012.

 

c) Cash and Cash Equivalents

 

The Company considers all highly-liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents as of September 30, 2013 or December 31, 2012.

 

d) Office Equipment and Depreciation

 

Office equipment is stated at cost and was depreciated using the straight line method over the estimated useful lives of the respective assets of three years. Routine maintenance, repairs and replacement costs are expensed as incurred and improvements that extend the useful life of the assets are capitalized. When office equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is recognized in operations. As of September 30, 2013 and December 31, 2012, all office equipment was fully depreciated.

 

F-6
 

 

e) Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeded the fair value of the assets.

 

f) Revenue Recognition

 

The Company recognizes revenue on arrangements in accordance with Securities and Exchange Commission Staff Accounting Bulletin Topic 13, Revenue Recognition and FASB ASC 605-15-25, Revenue Recognition. In all cases, revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed and collectability is reasonably assured. The Company did not report any revenues during the three or nine month periods ended September 30, 2013 or 2012.

 

g) Income Taxes

 

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Additionally, the recognition of future tax benefits, such as net operating loss carryforwards, is required to the extent that realization of such benefits is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the assets and liabilities are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income tax expense in the period that includes the enactment date.

 

In the event the future tax consequences of differences between the financial reporting bases and the tax bases of the Company’s assets and liabilities result in deferred tax assets, an evaluation of the probability of being able to realize the future benefits indicated by such asset is required. A valuation allowance is provided for the portion of the deferred tax asset when it is more likely than not that some or all of the deferred tax asset will not be realized. In assessing the realizability of the deferred tax assets, management considers the scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies.

 

The Company income tax returns are subject to examination by tax authorities. Generally, the statute of limitations related to the Company’s federal and state income tax return is three years from the date of filing. The state impact of any federal changes for prior years remains subject to examination for a period up to five years after formal notification to the states.

 

Management has evaluated tax positions in accordance with FASB ASC 740, Income Taxes, and has not identified any significant tax positions, other than those disclosed.

 

h) Subsequent Events

 

In accordance with FASB ASC 855, Subsequent Events, the Company evaluated subsequent events through April 2, 2014, the date the financial statements were available for release.

 

(4) Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company’s financial position and operating results raise substantial doubt about the Company’s ability to continue as a going concern, as reflected by the net losses of $25,697,282 accumulated through September 30, 2013. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Management is presently seeking to raise permanent equity capital in the capital markets to eliminate negative working capital and provide working capital. Failure to raise equity capital or secure some other form of long-term debt arrangement will cause the Company to further increase its negative working capital deficit and could result in the Company having to curtail or cease operations. Additionally, even if the Company does raise sufficient capital to support its operating expenses and generate revenues, there can be no assurances that the revenue will be sufficient to enable it to develop business to a level where it will generate profits and cash flows from operations.

 

F-7
 

 

(5) Stockholders’ Deficit

 

On February 9, 2012, the Company issued 15,553,005,984 shares. This issuance was to complete the GNE India asset purchase agreement of June 2010.

 

(6) Income Taxes

 

The items accounting for the difference between income taxes computed at the federal statutory rate and the provision for income taxes for the three and nine months ended September 30, 2013 and 2012 are as follows:

 

Income tax at federal statutory rate   (34.00)%
State tax, net of federal effect   (3.96)%
    37.96%
Valuation allowance   (37.96)%
Effective rate   0.00%

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

 

As of September 30, 2013 and December 31, 2012, the Company’s only significant deferred income tax asset was a cumulative estimated net tax operating loss of approximately $26 million that is available to offset future taxable income, if any, in future periods, subject to expiration and other limitations imposed by the Internal Revenue Service. Management has considered the Company’s operating losses incurred to date and believes that a full valuation allowance against the deferred tax assets is required as of September 30, 2013 and December 31, 2012.

 

(7) Related Parties

 

As of September 30, 2013 and December 31, 2012, the Company had $1,623 included in Due to affiliates in the accompanying consolidated balance sheet that is due to a stockholder. The amount is non-interest bearing and due upon demand.

 

As of September 30, 2013 and December 31, 2012, the Company had $59,157 and $55,564, respectively, included in Due to affiliates in the accompanying consolidated balance sheet that is due to a stockholder for amounts paid to certain vendors for services rendered. The amounts are non-interest bearing and due upon demand.

 

As of September 30, 2013 and December 31, 2012, the Company had $93,794 and $79,297, respectively, included in Due to affiliates in the accompanying consolidated balance sheet that is due to a stockholder and consultant of the Company for services rendered as a business advisor and for amounts paid to certain vendors for services rendered. The amounts are non-interest bearing and due upon demand.

 

As of September 30, 2013 and December 31, 2012, the Company had $58,000 and $52,000, respectively, included in Due to affiliates in the accompanying consolidated balance sheet that is due to a stockholder and consultant of the Company for services rendered as the Chief Executive Officer or the Company. The amounts are non-interest bearing and due upon demand.

 

As of September 30, 2013 and December 31, 2012, the Company had $117,598 and $96,358, respectively, included in Due to affiliates in the accompanying consolidated balance sheet that is due to a stockholder. The amount is non-interest bearing and due upon demand.

 

F-8
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our Financial Statements and Notes thereto appearing elsewhere in this Report on Form 10-Q as well as our other SEC filings.

 

Overview

 

The following discussion and analysis should be read in conjunction with the financial statements of the Company and the accompanying notes appearing subsequently under the caption “Financial Statements.”

 

This report on Form 10-Q contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking statements and from historical results of operations. Among the risks and uncertainties which could cause such a difference are those relating to our dependence upon certain key personnel, our ability to manage our growth, our success in implementing the business strategy, our success in arranging financing where required, and the risk of economic and market factors affecting us or our customers. Many of such risk factors are beyond the control of the Company and its management.

 

Management has not been satisfied with the results of its operations in the field of our current endeavors. Due to limited capital resources, it has not been able to properly promote or advertise its products. Moreover, even with increased brand awareness, competition in the field remains intense. As a result the Company is pursuing other business opportunities and has acquired all of the issued and outstanding shares of common stock of World Health. Assuming the Company can raise sufficient finances, the Company will focus its attention on the operations on World Health. In the interim, it will continue with its current operations.

 

Comparison of Operating Results for the Three and Nine Months Ended September 30, 2013 to the Three and Nine Months Ended September 30, 2012

 

Revenues

 

Revenues for three and nine month periods ended September 30, 2013 and 2012 were $0.

 

Operating Expenses

 

Operating expenses for the three month periods ended September 30, 2013 was $1,517 compared to $27,686 for the three month periods ended September 30, 2012. The reason for the decrease is due to there being a drop in the activities of the Company and therefore less need for consultancy and other professional fees. The Company did not incur any expense for office space during the three month period ended September 30, 2013, which was not the case for the three month period ended September 30, 2012.

 

Operating expenses for the nine month period ended September 30, 2013 were $48,161 compared to $110,447 for the nine month period ended September 30, 2012. The reason for the decrease is due to there being a drop in the activities of the Company and therefore less need for consultancy and other professional fees. The Company did not incur any expense for office space during the entire nine month period ended September 30, 2013, which was not the case for the nine month period ended September 30, 2012.

 

We recorded a net operating loss for the three month period ended September 30, 2013 of $1,517 compared to $27,686 for the three month period ended September 30, 2012.

 

We recorded a net operating loss for the nine month period ended September 30, 2013 of $48,161 compared to $110,447 for the six month period ended September 30, 2012.

 

Net Income/Loss and Net Income/Loss Per Share

 

Our net loss and net loss per share was $1,517 and $0.00 and $48,161 and $0.00, respectively, for the three and nine month periods ended September 30, 2013, compared to a $27,686 and $0.00 and $110,447 and $0.00, respectively, for the three and nine month periods ended September 30, 2012.

 

3
 

 

Financial Condition, Liquidity and Capital Resources

 

At September 30, 2013 and December 31, 2012, we had current and total assets of $0. We had current liabilities of $409,456 as compared to $361,295 as of September 30, 2013 and December 31, 2012, respectively. The increase is primarily due to shareholder advances used to fund operations.

 

At September 30, 2013, we had working capital deficiency of $409,456 as compared with a working capital deficiency of $361,295 at December 31, 2012.

 

If we need to obtain capital, no assurance can be given that we will be able to obtain this capital on acceptable terms, if at all. In such an event, this may have a materially adverse effect on our business, operating results and financial condition. If the need arises, we may attempt to obtain funding through the use of various types of short term funding, loans or working capital financing arrangements from banks or financial institutions.

 

Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern. We have stockholders deficit of $409,456 and a working capital deficiency of $409,456 at September 30, 2013 and net loss from operations of $1,517 and $27,686 for the three month periods ended September 30, 2013 and 2012, respectively, and $48,161 and $110,447 for the nine month periods ended September 30, 2013 and 2012, respectively. These conditions raise substantial doubt about our ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

 

Critical Accounting Policies

 

Use of Estimates The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the statements of financial condition and revenues and expenses for the year then ended. Actual results may differ significantly from those estimates.

 

Net loss per share The Company has adopted FASB ASC 260-10-50, Earnings Per Share, which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Basic and diluted losses per share were the same at the reporting dates as there were no common stock equivalents outstanding at September 30, 2013 or December 31, 2012.

 

Fair value of financial instruments The carrying values of the Company’s liabilities approximate their fair values due to the short maturity of these instruments.

 

Off-Balance Sheet Arrangements We have not entered into any off-balance sheet arrangements during 2013 and do not anticipate entering into any off-balance sheet arrangements during the next 12 months.

 

ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is not subject to any specific market risk other than that encountered by any other public company related to being publicly traded.

 

4
 

  

ITEM 4T - CONTROLS AND PROCEDURES

 

As required by Rule 13a-15 under the Exchange Act, within the 90 days prior to the filing date of this report, the Company carried out an evaluation of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. This evaluation was carried out under the supervision and with the participation of the Company’s management, including the Company’s President, Chief Executive Officer and Chief Financial Officer. Based upon that evaluation, the Company’s President, Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective. There have been no significant changes in the Company’s internal controls or in other factors, which could significantly affect internal controls subsequent to the date the Company carried out its evaluation.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in Company reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in Company reports filed under the Exchange Act is accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure.

 

PART II - OTHER INFORMATION

 

ITEM 1 LEGAL PROCEEDINGS

 

None

 

ITEM 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3 DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

None

 

ITEM 5 OTHER INFORMATION

 

None

 

5
 

 

ITEM 6 EXHIBITS

 

(a) The following sets forth those exhibits filed pursuant to Item 601 of Regulation S-K:

 

Exhibit   Number Descriptions
     
31.1   * Certification of the Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
     
31.2   * Certification of the Acting Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002.
     
32.1   * Certification Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
     
32.2   * Certification Acting Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002.
     
101.INS   † XBRL Instance Document
      
101.SCH   † XBRL Taxonomy Extension Schema Document
      
101.CAL   † XBRL Taxonomy Extension Calculation Linkbase Document
       
101.DEF   † XBRL Taxonomy Extension Definition Linkbase Document
       
101.LAB   † XBRL Taxonomy Extension Label Linkbase Document
       
101.PRE   † XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

* Filed herewith.

† Furnished herewith.

 

(b) The following sets forth the Company’s reports on Form 8-K that have been filed during the quarter for which this report is filed:

 

None

 

6
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  World Health Energy Holdings, Inc.  
     
Date: May 5, 2014 By: /s/ David Lieberman
    David Lieberman,
    President, CEO, Director

 

7